Cencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community Oncology
Company reiterates fiscal 2026 guidance Company raises long-term guidance expectations to reflect OneOncology’s expected long-term contribution to enterprise growth CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced it has entered into a definitive agreement to acquire the majority of the outstanding equity interests that it does not currently own in OneOncology, a physician-led national platform … [Read more…]
